Longitudinal Neoadjuvant and Post- operative Evaluation of Circulating Tumor DNA in Early Breast Cancer using a Tumor-Informed Assay: Updated Analysis of the TRACER Cohort

被引：1
作者：
Elliott, Mitchell
Antras, Jesus Fuentes
Echelard, Philippe
Dou, Aaron
Veitch, Zachary
Bedard, Philippe
Amir, Eitan
Nadler, Michelle
Meti, Nicholas
Gregorio, Nancy
Shah, Elizabeth
Yu, Celeste
Campbell, Nathan
Pipinikas, Christodoulos
Howarth, Karen
Siu, Lillian
Berman, Hal
Cescon, David
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PS06-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS06-08
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments
    Oh, Youjin
    Yoon, Sung Mi
    Lee, Jeeyeon
    Park, Joo Hee
    Lee, Soowon
    Hong, Timothy
    Chung, Liam Il-young
    Sudhaman, Sumedha
    Riddell, Timothy
    Palsuledesai, Charuta C.
    Krainock, Michael
    Liu, Minetta C.
    Chae, Young Kwang
    THORACIC CANCER, 2024, 15 (13) : 1095 - 1102
  • [22] Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancer
    Garcia-Murillas, Isaac
    Cutts, Rosalind J.
    Walsh-Crestani, Giselle
    Phillips, Edward
    Hrebien, Sarah
    Dunne, Kathryn
    Sidhu, Kally
    Daber, Robert
    Hubert, Benjamin
    Graybill, Chiharu
    Deford, Peter M.
    Wooten, David J.
    Zhao, Jianhua
    Ellsworth, Rachel E.
    Johnston, Stephen R. D.
    Ring, Alistair
    Russell, Simon
    Evans, Abigail
    Skene, Anthony
    Wheatley, Duncan
    Smith, Ian E.
    Korn, W. Michael
    Turner, Nicholas C.
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 209 (03) : 493 - 502
  • [23] Individualized tumor-informed circulating tumor DNA analysis for molecular residual disease detection in predicting recurrence and efficacy of adjuvant chemotherapy in colorectal cancer.
    Cao, Di
    Zhou, Qiaoxia
    Fan, Xuning
    Yang, Jinyu
    Li, Cong
    Wang, Fulong
    Zhang, Rongxin
    Wu, Xiaojun
    Li, Liren
    Lu, Zhenhai
    Pan, Zhizhong
    Lin, Junzhong
    Wu, Miaoqing
    Liu, Yifan
    Lv, Guangzhao
    Qiu, Fujun
    Xin, Haoyang
    Xu, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Circulating Tumour DNA (ctDNA) Detection and Dynamics in Patients with Early Breast Cancer (EBC): Results of the Neoadjuvant TRACER cohort
    Elliott, Mitchell J.
    Veitch, Zachary
    Bedard, Philippe
    Amir, Eitan
    Dou, Aaron
    Antras, Jesus Fuentes
    Nadler, Michelle
    Meti, Nicholas
    Gregorio, Nancy
    Shah, Elizabeth
    Chow, Helen
    Campbell, Nathan
    Terrell, Samantha
    Knape, Charlene
    Howarth, Karen
    Siu, Lillian
    Berman, Hal
    Cescon, David W.
    CANCER RESEARCH, 2023, 83 (05)
  • [25] Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA
    Chen, Jennifer H.
    Addanki, Sridevi
    Roy, Dhruvajyoti
    Bassett, Roland
    Kalashnikova, Ekaterina
    Spickard, Erik
    Kuerer, Henry M.
    Meas, Salyna
    Sarli, Vanessa N.
    Korkut, Anil
    White, Jason B.
    Rauch, Gaiane M.
    Tripathy, Debu
    Arun, Banu K.
    Barcenas, Carlos H.
    Yam, Clinton
    Sethi, Himanshu
    Rodriguez, Angel A.
    Liu, Minetta C.
    Moulder, Stacy L.
    Lucci, Anthony
    BMC CANCER, 2024, 24 (01)
  • [26] Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for postoperative monitoring of patients with stages I-III colorectal cancer (CRC).
    Zhou, Jian
    Yang, Jian
    Zhang, Zixiang
    Li, Ye
    Yi, Bin
    Tang, Yuchen
    Li, Dechun
    Li, Xiaozhe
    Peng, Di
    Li, Xi
    Wang, Yang
    Li, Haiyan
    Li, Bing
    Wang, Chenyang
    Zhu, Pengfei
    Chen, Longfei
    Wu, Shuailai
    Fang, Shuai
    Li, Chenxi
    Qiu, Fujun
    Chuai, Shannon
    Zhang, Zhihong
    CANCER RESEARCH, 2022, 82 (12)
  • [27] Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy
    Li, Shunying
    Lai, Hongna
    Liu, Jieqiong
    Liu, Yujie
    Jin, Liang
    Li, Yudong
    Liu, Fengtao
    Gong, Yuhua
    Guan, Yanfang
    Yi, Xin
    Shi, Qianfeng
    Cai, Zijie
    Li, Qian
    Li, Ying
    Zhu, Mengdi
    Wang, Jingru
    Yang, Yaping
    Wei, Wei
    Yin, Dong
    Song, Erwei
    Liu, Qiang
    JCO PRECISION ONCOLOGY, 2020, 4 : 244 - 257
  • [28] Early detection of circulating tumor DNA for the assessment of resistance or relapse to neoadjuvant chemotherapy in breast cancer patients
    Isnaldi, E.
    Ferrando, L.
    Garuti, A.
    Cirmena, G.
    Franceschelli, P.
    Fregatti, P.
    Garlaschi, A.
    Friendman, D.
    Ballestrero, A.
    Zoppoli, G.
    ANNALS OF ONCOLOGY, 2017, 28 : 5 - 5
  • [29] Performance characteristics of a tumor-informed circulating tumor DNA (ctDNA) minimal residual disease (MRD) assay in stage 1-3 colorectal cancer (CRC) in clinical practice
    Somer, B.
    Mehler, S.
    Hasenburg, A.
    Greene, H.
    Tauer, K.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S347 - S347
  • [30] Clinical Benefit of Circulating Tumor DNA Analysis in Early-Stage Breast Cancer
    Chitkara, Garvit
    Hawaldar, Rohini
    Badwe, Rajendra A.
    JAMA ONCOLOGY, 2020, 6 (03) : 439 - 439
12345